Company Updates

Our commitment to DE&I underscores our true belief that encouraging the voices from different backgrounds will enrich our work experiences, contribute to better decision making and ultimately, greatly benefit our patients.

We have furthered our reach into the development of cardiac gene therapies in a partnership with Swiss biotech DiNAQOR

We have been committed to the rare disease community and sustainbility for 22 years. Learn more about our commitment here: http://glassdoor.com/slink.htm?key=vM0P3

Meet some of our MDs and PhDs and hear about their journey to science, medicine and BioMarin! http://glassdoor.com/slink.htm?key=vMEay

Get to know our gene therapy team. We’re committed to blazing the trail with research and treatments that help the rare disease community. http://glassdoor.com/slink.htm?key=vMdWs

BioMarin has been ranked #4 on Forbes magazine's 2019 list of "America's Best Midsize Employers," and was ranked first among its peers in the ‘Drugs & Biotechnology’ industry! We’re proud of this year’s accomplishment and of our previous Forbes recognitions on its "Most Innovative Companies" and “World's Best Employers” lists. Read more about these achievements here: http://glassdoor.com/slink.htm?key=vM5WS

We consider ourselves #RareDisease research pioneers. Our employees are ambitious and determined, always breaking barriers and pushing boundaries in the hopes of discovering successful and life changing treatments. Join our team: http://glassdoor.com/slink.htm?key=vMCng

Our cutting-edge research makes us unique while our goal to help the rare disease community brings us together. Watch to learn more about our research approach. http://glassdoor.com/slink.htm?key=vQZWj

Did you know BioMarin built one of the first gene therapy manufacturing facilities in the world? Located in Novato, California, this site is home to our research pioneers.

We’re honored to receive our second recognition by Forbes as a best employer in 2018. This time on a global scale as one of “The World’s Best Employers 2018”! http://glassdoor.com/slink.htm?key=vQxcq